Bayer CropScience Ltd

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical parameters suggest caution for investors amid persistent downward pressures.

Bayer CropScience Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Sell to Hold as of 3 August 2026. This change reflects a nuanced improvement across technical indicators, financial trends, valuation metrics, and quality assessments, signalling a cautious but positive outlook for investors amid challenging market conditions.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.58%, the stock’s mixed signals across MACD, RSI, moving averages, and other momentum indicators suggest cautious optimism amid ongoing volatility in the pesticides and agrochemicals sector.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Hold to Sell as of 27 Jul 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, subdued financial trends, and overall quality assessments, signalling caution for investors despite some positive quarterly financial results.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite a recent upgrade in its Mojo Grade from Sell to Hold. The stock’s price momentum and technical parameters reveal a complex picture for investors navigating the pesticides and agrochemicals sector amid broader market pressures.

Bayer CropScience Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This shift comes amid a backdrop of mixed long-term returns but encouraging recent financial performance and a stabilising technical outlook.

Bayer CropScience Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 2.18% gain on 22 Jul 2026, the stock’s broader trend remains cautious, with mixed signals from MACD, RSI, moving averages, and volume-based indicators suggesting a nuanced market sentiment for this small-cap player in the pesticides and agrochemicals sector.

Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bayer CropScience Ltd’s share price declined to a fresh 52-week low of Rs.4100 on 29 June 2026, marking a significant downturn amid broader market resilience. The stock has underperformed its sector and key indices, reflecting ongoing concerns about its valuation and growth trajectory.

For the fifth consecutive session, Bayer CropScience Ltd closed lower, slipping to a fresh 52-week low of Rs 4179 on 22 Jun 2026, marking a significant 36% decline from its 52-week high of Rs 6539.95. This downturn contrasts sharply with the broader market's resilience, as the Sensex gained 0.55% and continues a three-week rally.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with an up-to-date perspective on the company’s standing.

For the second consecutive session, Bayer CropScience Ltd has declined, hitting a fresh 52-week low of Rs 4,192.7 on 17 Jun 2026, marking a 2.01% drop over the last two days amid broader sector weakness.

A sharp decline has pushed Bayer CropScience Ltd to a fresh 52-week low of Rs 4,230.9 on 11 Jun 2026, marking a significant 35.3% drop from its peak of Rs 6,539.95 within the last year. This downturn comes despite some encouraging financial metrics, highlighting a complex interplay of valuation concerns and market sentiment.

Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 10 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Bayer CropScience Ltd’s share price declined to a fresh 52-week low of Rs.4248 on 09 Jun 2026, marking a continuation of recent downward momentum amid broader market pressures and company-specific valuation concerns.

A sharp decline over the past two sessions has dragged Bayer CropScience Ltd to a fresh 52-week low of Rs 4265.4 on 8 Jun 2026, marking a 3.25% drop in just 48 hours amid broader sector weakness and persistent selling pressure.